These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21562721)

  • 1. Bioadhesive microspheres for bioavailability enhancement of raloxifene hydrochloride: formulation and pharmacokinetic evaluation.
    Jha RK; Tiwari S; Mishra B
    AAPS PharmSciTech; 2011 Jun; 12(2):650-7. PubMed ID: 21562721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and evaluation of solid lipid nanoparticles of raloxifene hydrochloride for enhanced bioavailability.
    Kushwaha AK; Vuddanda PR; Karunanidhi P; Singh SK; Singh S
    Biomed Res Int; 2013; 2013():584549. PubMed ID: 24228255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly(methyl vinyl ether-co-maleic acid) for enhancement of solubility, oral bioavailability and anti-osteoporotic effects of raloxifene hydrochloride.
    Varshosaz J; Minaiyan M; Dayyani L
    Eur J Pharm Sci; 2018 Jan; 112():195-206. PubMed ID: 29196024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral bioavailability enhancement of raloxifene by developing microemulsion using D-optimal mixture design: optimization and in-vivo pharmacokinetic study.
    Shah N; Seth A; Balaraman R; Sailor G; Javia A; Gohil D
    Drug Dev Ind Pharm; 2018 Apr; 44(4):687-696. PubMed ID: 29168671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucoadhesive microspheres for gastroretentive delivery of acyclovir: in vitro and in vivo evaluation.
    Dhaliwal S; Jain S; Singh HP; Tiwary AK
    AAPS J; 2008 Jun; 10(2):322-30. PubMed ID: 18523891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced dissolution and bioavailability of raloxifene hydrochloride by co-grinding with different superdisintegrants.
    Jagadish B; Yelchuri R; K B; Tangi H; Maroju S; Rao VU
    Chem Pharm Bull (Tokyo); 2010 Mar; 58(3):293-300. PubMed ID: 20190431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of a new platform based on fumed and mesoporous silica nanoparticles for enhanced solubility and oral bioavailability of raloxifene HCl.
    Varshosaz J; Dayani L; Chegini SP; Minaiyan M
    IET Nanobiotechnol; 2019 Jun; 13(4):392-399. PubMed ID: 31171744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A matrix dispersion based on phospholipid complex system: preparation, lymphatic transport, and pharmacokinetics.
    Li H; Lu S; Luo M; Li X; Liu S; Zhang T
    Drug Dev Ind Pharm; 2020 Apr; 46(4):557-565. PubMed ID: 32126844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability Enhancement of BCS Class II Raloxifene Hydrochloride by Inclusion Complex and Solid Dispersion Techniques.
    Kher JD; Sorathia K
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2024 Jun; 40():e20240002. PubMed ID: 38862271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation, development and optimization of raloxifene-loaded chitosan nanoparticles for treatment of osteoporosis.
    Saini D; Fazil M; Ali MM; Baboota S; Ali J
    Drug Deliv; 2015; 22(6):823-36. PubMed ID: 24725026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and evaluation of mucoadhesive glipizide microspheres.
    Patel JK; Patel RP; Amin AF; Patel MM
    AAPS PharmSciTech; 2005 Sep; 6(1):E49-55. PubMed ID: 16353963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo, in vitro evaluation of linseed mucilage based buccal mucoadhesive microspheres of venlafaxine.
    Nerkar PP; Gattani S
    Drug Deliv; 2011 Feb; 18(2):111-21. PubMed ID: 20954808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioadhesive polymer/lipid hybrid nanoparticles as oral delivery system of raloxifene with enhancive intestinal retention and bioavailability.
    Du X; Gao N; Song X
    Drug Deliv; 2021 Dec; 28(1):252-260. PubMed ID: 33501870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of Piperine Pro-Nano Lipospheres on Direct Intestinal Phase II Metabolism: The Raloxifene Paradigm of Enhanced Oral Bioavailability.
    Izgelov D; Cherniakov I; Aldouby Bier G; Domb AJ; Hoffman A
    Mol Pharm; 2018 Apr; 15(4):1548-1555. PubMed ID: 29537855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of a transdermal formulation containing raloxifene nanoparticles for osteoporosis treatment.
    Nagai N; Ogata F; Otake H; Nakazawa Y; Kawasaki N
    Int J Nanomedicine; 2018; 13():5215-5229. PubMed ID: 30233182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefdinir nanosuspension for improved oral bioavailability by media milling technique: formulation, characterization and in vitro-in vivo evaluations.
    Sawant KK; Patel MH; Patel K
    Drug Dev Ind Pharm; 2016; 42(5):758-68. PubMed ID: 26548349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioavailability enhancement of verapamil HCl via intranasal chitosan microspheres.
    Abdel Mouez M; Zaki NM; Mansour S; Geneidi AS
    Eur J Pharm Sci; 2014 Jan; 51():59-66. PubMed ID: 23999035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of mucoadhesive microspheres of acyclovir with enhanced bioavailability.
    Tao Y; Lu Y; Sun Y; Gu B; Lu W; Pan J
    Int J Pharm; 2009 Aug; 378(1-2):30-6. PubMed ID: 19465102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation, development, and performance evaluation of metoclopramide HCl oro-dispersible sustained release tablet.
    Kasliwal N; Negi JS; Jugran V; Jain R
    Arch Pharm Res; 2011 Oct; 34(10):1691-700. PubMed ID: 22076769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanochemically induced solid state transformations: The case of raloxifene hydrochloride.
    de Oliveira YS; Oliveira AC; Ayala AP
    Eur J Pharm Sci; 2018 Mar; 114():146-154. PubMed ID: 29198613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.